Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
Tynan M, Peshkin BN, Isaacs C, Willey S, Valdimarsdottir HB, Nusbaum R, Hooker G, O'Neill SC, Jandorf L, Kelly SP, Heinzmann J, Kelleher S, Poggi E, Schwartz MD.
Tynan M, et al.
Breast Cancer Res Treat. 2020 Feb;180(1):177-185. doi: 10.1007/s10549-019-05515-2. Epub 2020 Jan 1.
Breast Cancer Res Treat. 2020.
PMID: 31894446
Free PMC article.